Nico Gong

the lab

Research

2026

SETDB1 in Breast Cancer Progression: Oncogenic Mechanisms and Subtype-Specific Prognostic Implications

First Author

My second published paper — a study of SETDB1, a histone methyltransferase whose oncogenic effects span tumor-suppressor silencing, cancer stem cell maintenance, and immune evasion, and how its prognostic role shifts across breast cancer subtypes in TCGA, METABRIC, and KM Plotter datasets.

read the paper →

2026

Bacillus Thuringiensis Cry Proteins: A Review of Anti-Tumor Potential and Clinical Applicability

First Author

My first published paper — a review of parasporins, a subclass of B. thuringiensis Cry proteins with anti-tumor properties, and whether each family is selective enough toward specific cancers to be applicable in clinical oncology.

read the paper →

Summer 2025 · University of Iowa · Carver College of Medicine

SETDB1 Gene's Role in Endometrial Cancer Progression in Lean and Obese Models

Summer Researcher

My 2025 cancer research at SSTP, in the pathology labs of Iowa's Carver College of Medicine — exploring SETDB1's pro-tumor properties through immune regulation, comparing tumor growth in lean and obese mouse models.

SETDB1 Gene's Role in Endometrial Cancer Progression in Lean and Obese Models